Tumor Irradiation

Март 2, 2021

Содержание

2. Figure 2 Routes of Administration Intravenous Intranodal Subcutaneous Intradermal Tumor Lysate Whole tumor mRNA extracts Plasmacytoid
3. Priming modalities Personalized synthetic vaccine Boosting Synthetic vaccine Synthetic vaccine Synthetic vaccine Standard of care/ in
4. Info for the next slide:
6. Скачать презентацию

Слайд 2

Figure 2
Routes of Administration
Intravenous
Intranodal
Subcutaneous
Intradermal
Tumor Lysate
Whole tumor
mRNA extracts
Plasmacytoid DC
B cell
Immunogenic treatments
exosomes
Antigen types
HOCl oxidation
UV

Figure 2 Routes of Administration Intravenous Intranodal Subcutaneous Intradermal Tumor Lysate Whole

irradiation

Heat shock

hyperthermia

Principal APCs

Microneedle patches

3d synthetic scaffolds

Synthetic encapsulation

Routes of
administration

cDC1

cDC2

iDCs

macrophage

CD123+
CD11c-
CD303+
CD304+

CD123-
CD11c+
CD141+
Clec9A+

CD123-
CD11c+
CD1c+
Clec9A-

CD16-
CD11c+

CD19+
CD20+

liposome

Synthetic polymer
nsnoparticle

hydrogel

Слайд 3

Priming modalities
Personalized synthetic vaccine
Boosting
Synthetic vaccine
Synthetic vaccine
Synthetic vaccine
Standard of care/ in situ approaches
Radiotherapy
Chemotherapy
Cryoablation
Immunomodulation
Whole

Priming modalities Personalized synthetic vaccine Boosting Synthetic vaccine Synthetic vaccine Synthetic vaccine

tumor vaccine

Patient interrogation

*

Blood collection and tumor biopsy

Слайд 4

Info for the next slide:

Info for the next slide: